Biodesix, Inc.
BDSX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $21 | $18 | $26 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $13 | $7 | $8 | $9 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $4 | $5 |
| Total Curr. Assets | $33 | $32 | $30 | $39 |
| Property Plant & Equip (Net) | $31 | $28 | $29 | $30 |
| Goodwill | $15 | $15 | $15 | $15 |
| Intangibles | $4 | $5 | $5 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $7 | $7 | $9 |
| Total NC Assets | $55 | $55 | $57 | $60 |
| Other Assets | $0 | $0 | $0 | -$2 |
| Total Assets | $89 | $88 | $86 | $97 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $1 | $1 | $1 |
| Other Curr. Liab. | $10 | $10 | $8 | $11 |
| Total Curr. Liab. | $18 | $15 | $13 | $14 |
| LT Debt | $72 | $71 | $61 | $61 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $3 |
| Total NC Liab. | $72 | $71 | $62 | $64 |
| Other Liabilities | $0 | $0 | $0 | -$2 |
| Cap. Leases | $24 | $25 | $26 | $26 |
| Total Liabilities | $90 | $87 | $75 | $76 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$494 | -$485 | -$474 | -$462 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $492 | $486 | $485 | $483 |
| Total Equity | -$2 | $1 | $11 | $21 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $89 | $88 | $86 | $97 |
| Net Debt | $56 | $51 | $45 | $36 |